Abstract
Abstract
Background
Social robots have demonstrated promising outcomes in terms of increasing the social health and well-being of people with dementia and mild cognitive impairment. According to the World Health Organization’s Monitoring and assessing digital health interventions framework, usability and feasibility studies are crucial before implementing prototype social robots and proving their efficacy and effectiveness. This protocol paper aims to detail the plan for conducting the usability and feasibility study of the MINI robot based on evidence-based recommended methodology.
Methods
In this study, an experimental design and a mixed method of data collection will be applied. Twenty participants aged 65 and over with dementia or mild cognitive impairment will be recruited. Eight sessions of interaction with the robot, as well as qualitative and quantitative assessments, will be accomplished. The research will take place in a laboratory. Ethical approvals have been acquired. This research will be valuable in the development of the MINI robot and its practical deployment in the actual world, as well as the methodological evidence base in the sector of social robots.
Discussion
By the winter of 2022–2023, the findings of this study will be accessible for dissemination. This study will aid to improve the evidence-based methodology used to study the feasibility and usability of social robots in people with dementia and mild cognitive impairment as well as what can be learned to advance such study designs in the future.
Funder
H2020 Marie Skłodowska-Curie Actions
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference24 articles.
1. Dementia in Europe Yearbook 2019 [https://www.alzheimer-europe.org/resources/publications/dementia-europe-yearbook-2019-estimating-prevalence-dementia-europe].
2. Adames HY, Tazeau YN. Caring for Latinxs with Dementia in a Globalized World. Springer; 2020.
3. Dyer AH, Murphy C, Lawlor B, Kennelly SP, Study Group For The N. Social networks in mild-to-moderate Alzheimer disease: longitudinal relationships with dementia severity, cognitive function, and adverse events. Aging Ment Health. 2020;25:1923–9.
4. Chang F, Patel T, Schulz ME. The "rising tide" of dementia in Canada: what does it mean for pharmacists and the people they care for? Can Pharm J (Ott). 2015;148(4):193–9.
5. Gordijn B, Have HT. Technology and dementia. Med Health Care Philos. 2016;19(3):339–40.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献